Company intelligence / Profile preview
Berlin-Chemie AG
Adlershof/Britz/Berlin proper, Berlin, Germanyberlin-chemie.de ↗
- Ownership
- Private
- Employees
- ~5000
- Development stage
- Commercial
01
Overview
Berlin-Chemie AG develops and markets a broad range of pharmaceutical products across multiple therapeutic areas. Its commercialized portfolio includes cardiovascular medicines (such as modern antihypertensives), diabetes treatments, pain medications, respiratory therapies and more. In oncology research—via partnership with Oxford BioTherapeutics—the company has several antibody-based drug candidates under development. The majority of its marketed products are small molecule generics or branded medicines.
- Therapeutic areas
- PulmonologyOncologyEndocrinologyImmunologyGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculesAntibody-based drugs
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Oxford BioTherapeutics
Beyond the preview
Go deeper on Berlin-Chemie AG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Berlin-Chemie AG.